New pacemaker strategy could cut heart failure deaths after valve surgery
NCT ID NCT07434193
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a special type of pacemaker, called cardiac resynchronization therapy (CRT), can help people with heart failure who develop a heart block after having their aortic valve replaced. The trial will include 360 adults who have a new, persistent heart block and moderately reduced heart function after a successful valve procedure. The goal is to see if early use of this pacemaker reduces the chance of being hospitalized for heart failure or dying within a year.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Semmelweis University, Heart and Vascular Center
RECRUITINGBudapest, 1122, Hungary
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI ultrasound could unmask silent heart disease in seniors
- Can a diabetes drug tame chronic heart failure? a Real-World study investigates
- Heart valve fix without the hospital stay? trial tests Same-Day discharge
- Can a wearable monitor prevent heart emergencies after valve replacement?
- Heart rehab goes hybrid: can a mix of home and clinic sessions boost adherence?
- Mountain air or heart risk? trial asks if high altitude is safe for aortic stenosis patients.